FDA Inspection 955689 — Merck & Co. Inc

Merck & Co. Inc — FEI 2211017

The FDA completed an inspection of Merck & Co. Inc on Nov 19, 2015 in Rahway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 19, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rahway, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol
748221 CFR 312.50General responsibilities of sponsors
755821 CFR 312.57(c)Record retention requirement

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.